IGC Pharma, Inc. Share Price & Technical Analysis
IGC · $0.28 (-3.45%)
Healthcare / Biotechnology
$0.28
-3.45%
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product can…
Price chart
Seasonality
May has 0 positive and 3 negative years (last 5 years shown)
0% return in May, -14% avg return in past 3 year May month.
0% return in 2026, 1% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 0% | 0% | 0% | 0% | – | – | – | – | – | – | – | 0% |
| 25 | 0% | 0% | 0% | 0% | 0% | 0% | 33% | 33% | 0% | 0% | -25% | 0% | 42% |
| 24 | 0% | 0% | 0% | 25% | -17% | -20% | 25% | -20% | 0% | 0% | 0% | -25% | -32% |
| 23 | 33% | 0% | -25% | 0% | -25% | 0% | 0% | 0% | 33% | -25% | 0% | 0% | -8% |
| 22 | 0% | 22% | -18% | -22% | -43% | 25% | -17% | 20% | -20% | 0% | -20% | -25% | -98% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Oversold
IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$29.26M
P/E ratio
—
52W high
$0.50
52W low
$0.24
Volume
2,97,351
Beta
0.50
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is IGC Pharma, Inc. share price today?
- IGC Pharma, Inc. (IGC) last traded around $0.28 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does IGC have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for IGC. Download the app for real-time alerts.
- How can I analyze IGC Pharma, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.